Gout showdown: which treatment strategy wins?
NCT ID NCT04875702
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing two common ways to manage gout: one that aims to lower uric acid levels to a specific target, and another that treats flare symptoms as they happen. Researchers will track 650 adults with gout over two years to see which approach leads to fewer gout attacks and better overall health. The goal is to find out which strategy works best for patients in everyday care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Allopurinol (a medication to lower uric acid), along with anti-inflammatory drugs (naproxen, colchicine, prednisone) for symptom control
What this could lead to
If successful, this trial could show that one approach to managing gout is clearly better than the other, helping doctors and patients choose the most effective strategy to reduce painful flares and improve quality of life.
What could go wrong
This is a phase 4 trial comparing existing strategies, not testing a new breakthrough treatment. The results may show no major difference between the two approaches, or the benefits may vary widely among individuals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Medical Center (BMC)
NOT_YET_RECRUITINGBoston, Massachusetts, 02119, United States
Contact Email: •••••@•••••
-
Brigham and Women's Hospital (BWH)
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NYU Langone
RECRUITINGNew York, New York, 10010, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
The University of Alabama at Birmingham
NOT_YET_RECRUITINGSouth Birmingham, Alabama, 35233, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
UCLA Health
NOT_YET_RECRUITINGSanta Monica, California, 90404, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
West Virginia University (Including Mobile Clinical Trials Unit)
NOT_YET_RECRUITINGMorgantown, West Virginia, 26506, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact